These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 32240804)

  • 21. Protein-Polydimethylsiloxane Particles in Liquid Vial Monoclonal Antibody Formulations Containing Poloxamer 188.
    Grapentin C; Müller C; Kishore RSK; Adler M; ElBialy I; Friess W; Huwyler J; Khan TA
    J Pharm Sci; 2020 Aug; 109(8):2393-2404. PubMed ID: 32194095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, characterization and assessment of suitability of trehalose fatty acid esters as alternatives for polysorbates in protein formulation.
    Schiefelbein L; Keller M; Weissmann F; Luber M; Bracher F; Friess W
    Eur J Pharm Biopharm; 2010 Nov; 76(3):342-50. PubMed ID: 20816956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The measurement and control of high-risk host cell proteins for polysorbate degradation in biologics formulation.
    Li X; Wang F; Li H; Richardson DD; Roush DJ
    Antib Ther; 2022 Jan; 5(1):42-54. PubMed ID: 35155990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parenteral protein formulations: An overview of approved products within the European Union.
    Gervasi V; Dall Agnol R; Cullen S; McCoy T; Vucen S; Crean A
    Eur J Pharm Biopharm; 2018 Oct; 131():8-24. PubMed ID: 30006246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanistic understanding of metal-catalyzed oxidation of polysorbate 80 and monoclonal antibody in biotherapeutic formulations.
    Bensaid F; Dagallier C; Authelin JR; Audat H; Filipe V; Narradon C; Guibal P; Clavier S; Wils P
    Int J Pharm; 2022 Mar; 615():121496. PubMed ID: 35074436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simultaneous quantification of polysorbate 20 and poloxamer 188 in biopharmaceutical formulations using evaporative light scattering detection.
    Paschen CA; Klemm D; Graf T; Kopf R; Pinto C; Müller C; Bell CH; Pfaff J
    J Pharm Biomed Anal; 2021 Jan; 192():113640. PubMed ID: 33002754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CMC determination of nonionic surfactants in protein formulations using ultrasonic resonance technology.
    Horiuchi S; Winter G
    Eur J Pharm Biopharm; 2015 May; 92():8-14. PubMed ID: 25684280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Excipients in parenteral formulations: selection considerations and effective utilization with small molecules and biologics.
    Rayaprolu BM; Strawser JJ; Anyarambhatla G
    Drug Dev Ind Pharm; 2018 Oct; 44(10):1565-1571. PubMed ID: 29863908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhomogeneous Distribution of Components in Solid Protein Pharmaceuticals: Origins, Consequences, Analysis, and Resolutions.
    Nguyen KTT; Frijlink HW; Hinrichs WLJ
    J Pharm Sci; 2020 Jan; 109(1):134-153. PubMed ID: 31606540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Comprehensive Scientific Survey of Excipients Used in Currently Marketed, Therapeutic Biological Drug Products.
    Rao VA; Kim JJ; Patel DS; Rains K; Estoll CR
    Pharm Res; 2020 Sep; 37(10):200. PubMed ID: 32968854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel markers to track oxidative polysorbate degradation in pharmaceutical formulations.
    Dahotre S; Tomlinson A; Lin B; Yadav S
    J Pharm Biomed Anal; 2018 Aug; 157():201-207. PubMed ID: 29803911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of the specific causes of polysorbate 20 degradation in monoclonal antibody formulations containing multiple lipases.
    Zhang S; Riccardi C; Kamen D; Reilly J; Mattila J; Bak H; Xiao H; Li N
    Pharm Res; 2022 Jan; 39(1):75-87. PubMed ID: 34981317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formulation and manufacturability of biologics.
    Shire SJ
    Curr Opin Biotechnol; 2009 Dec; 20(6):708-14. PubMed ID: 19880308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent trends in stabilising peptides and proteins in pharmaceutical formulation - considerations in the choice of excipients.
    Jorgensen L; Hostrup S; Moeller EH; Grohganz H
    Expert Opin Drug Deliv; 2009 Nov; 6(11):1219-30. PubMed ID: 19678792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polysorbate degradation in biotherapeutic formulations: Identification and discussion of current root causes.
    Dwivedi M; Blech M; Presser I; Garidel P
    Int J Pharm; 2018 Dec; 552(1-2):422-436. PubMed ID: 30300706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid Polysorbate 80 Degradation by Liver Carboxylesterase in a Monoclonal Antibody Formulated Drug Substance at Early Stage Development.
    Zhang S; Xiao H; Molden R; Qiu H; Li N
    J Pharm Sci; 2020 Nov; 109(11):3300-3307. PubMed ID: 32721471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Stabilizing Excipients in Dry State Therapeutic Phage Formulations.
    Zhang Y; Zhang H; Ghosh D
    AAPS PharmSciTech; 2020 May; 21(4):133. PubMed ID: 32415395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization and stability study of polysorbate 20 in therapeutic monoclonal antibody formulation by multidimensional ultrahigh-performance liquid chromatography-charged aerosol detection-mass spectrometry.
    Li Y; Hewitt D; Lentz YK; Ji JA; Zhang TY; Zhang K
    Anal Chem; 2014 May; 86(10):5150-7. PubMed ID: 24749737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of Super Refined™ Polysorbate 20 With Respect to Polysorbate Degradation, Particle Formation and Protein Stability.
    Doshi N; Fish R; Padilla K; Yadav S
    J Pharm Sci; 2020 Oct; 109(10):2986-2995. PubMed ID: 32679214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ester hydrolysis of polysorbate 80 in mAb drug product: evidence in support of the hypothesized risk after the observation of visible particulate in mAb formulations.
    Labrenz SR
    J Pharm Sci; 2014 Aug; 103(8):2268-77. PubMed ID: 24942482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.